Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Open Access statistics for Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Australia, covering academic research published from 2012 to 2024.

Open Access statistics for Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Australia, covering academic research published from 2012 to 2024. Read More.


Open Access Percentage

54%


Total
Publications

106


Total Open
Publications

57


Total
Citations

5.7K


Open Access
Percentage

54%


Total
Publications

106


Total Open
Publications

57


Total
Citations

5.7K

Website

download

Breakdown

18% 30% 6% 46%

Publisher Open

18%

Both

30%

Other Platform Open

6%

Closed

46%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
2012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

31%OA Journal

OA Journal 31%

16

Hybrid 49%

25

No Guarantees 20%

10

Other Platform Open

Domain 74%

28

Institution 53%

20

Other Internet 5%

2

Public 3%

1

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
28
University College London - UCL Discovery
Institution
11
University of Melbourne - Minerva Access
Institution
5
Monash University - Monash University Research Portal
Institution
4
Europe PMC
Domain
4
Universitas Airlangga - Universitas Airlangga Repository
Institution
3
unimelb.edu.au OAI-PMH Repository
Institution
3
University of Technology Sydney - Open Publications Of UTS Scholars
Institution
2
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
2
Robert Gordon University - OpenAIR@RGU
Other Internet
2
1 / 3

Data updated 7 April 2025

Share

Share

Share